Literature DB >> 310920

A preliminary note on the composition of lymphocytes in human peripheral lymph.

T Godal, A Engeset.   

Abstract

Pilot experiments on the composition of lymphocytes in human peripheral lymph, mainly from healthy human volunteers, are presented. The experiments undertaken so far show a reduced proportion of B cells and an increased proportion of "Ia" positive lymphocytes in peripheral lymph as compared to peripheral blood. If confirmed, these data would suggest that lymphocyte circulation through extravascular subcutaneous tissues is a highly selective process.

Entities:  

Mesh:

Year:  1978        PMID: 310920

Source DB:  PubMed          Journal:  Lymphology        ISSN: 0024-7766            Impact factor:   1.286


  6 in total

Review 1.  Lymphocytes. 3. Distribution. Distribution of lymphocytes in health.

Authors:  W L Ford
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1979

2.  Role of lymphocytes in non-immune experimental inflammation.

Authors:  J Garcia-Leme
Journal:  Agents Actions       Date:  1981-12

3.  Preliminary evidence of dual-marked lymphocytes in thoracic duct lymph fluid.

Authors:  J C Cicciarelli; Y Iwaki; P I Terasaki; K Guidera; S Shirahama; R Billing; M Hermes; L Cardman; T Kano; S Iwatsuki; L Koep; R Weil; T E Starzl
Journal:  Transplant Proc       Date:  1980-09       Impact factor: 1.066

4.  Lymphocytes in non-immune inflammation: a specific subclass of lymphoid cells?

Authors:  J G Leme; S B Verissimo de Mello; R P Falcao; J R Rocha
Journal:  Br J Exp Pathol       Date:  1981-04

5.  Large mononuclear (veiled) cells like 'Ia-like' membrane antigens in human afferent lympn.

Authors:  C J Spry; A J Pflug; G Janossy; J H Humphrey
Journal:  Clin Exp Immunol       Date:  1980-03       Impact factor: 4.330

6.  Lymphocyte subsets show marked differences in their distribution between blood and the afferent and efferent lymph of peripheral lymph nodes.

Authors:  C R Mackay; W G Kimpton; M R Brandon; R N Cahill
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.